HIFU and potential immune response in cancer therapy
George Suarez, International HIFU Centers
5 November 2007
We have been using HIFU in combination with autologous patient's Dendrite cell therapy for advanced prostate cancer with excellent outcomes. There is no doubt that the combination therapy holds great promise for advanced stage desease in prostate cancer, as well as potential other types of cancer. For more information visit www.internationalhifucenters.com
Competing interests
I am the Medical Director for the International HIFU Centers.
HIFU and potential immune response in cancer therapy
5 November 2007
We have been using HIFU in combination with autologous patient's Dendrite cell therapy for advanced prostate cancer with excellent outcomes. There is no doubt that the combination therapy holds great promise for advanced stage desease in prostate cancer, as well as potential other types of cancer. For more information visit www.internationalhifucenters.com
Competing interests
I am the Medical Director for the International HIFU Centers.